CompletedNCT00001656
Clozapine or olanzapine for psychosis in young people
About this title
Read the official source — NCT00001656Medication studyAges 7–18United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 7 years to 18 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 1997
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 7 Years to 18 Years
- Official registry ID
- NCT00001656
- Official title
Show the full official title
Childhood Onset Psychotic Disorders: Characterization and Treatment With Atypical Neuroleptics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine and Clozapine.
Who was this study for?
Listed age limits: 7 years to 18 years.
